Camber Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$72.4M Sell
1,050,000
-1,200,000
-53% -$78.7M 6.8% 5
2025
Q1
$152M Sell
2,250,000
-750,000
-25% -$44.9M 5.42% 7
2024
Q4
$135M Buy
3,000,000
+1,500,000
+100% +$84.2M 3.11% 10
2024
Q3
$94.3M Hold
1,500,000
3% 14
2024
Q2
$88.6M Buy
+1,500,000
New +$93.8M 2.45% 16

Other funds holding CVS

Camber Capital Management's CVS Position: Q2 2025 in Review

Camber Capital Management reduced its CVS Health (CVS) stake by 53% in Q2 2025, selling an estimated $78.7M and leaving 1,050,000 shares worth $72.4M. The position accounts for 6.8% of the portfolio, ranked #5.

Camber Capital Management first reported a position in CVS in Q2 2024 and has held it in 5 quarters since. The position peaked at $152M in Q1 2025. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Camber Capital Management held 1,050,000 shares of CVS Health worth $72.4M as of Q2 2025.
  • Camber Capital Management sold 1,200,000 CVS Health shares in Q2 2025, an estimated $78.7M.
  • CVS Health made up 6.8% of Camber Capital Management's portfolio in Q2 2025, its #5 holding.
  • Camber Capital Management first reported a position in CVS Health in Q2 2024 and has held it in 5 quarters since.
  • Camber Capital Management's CVS Health position peaked at $152M in Q1 2025.
  • 1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Camber Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.